Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

ratiopharm gmbh* - losartanum kalíum - filmuhúðuð tafla - 100 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

ratiopharm gmbh* - losartanum kalíum - filmuhúðuð tafla - 25 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

ratiopharm gmbh* - losartanum kalíum - filmuhúðuð tafla - 50 mg

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin, linagliptin - sykursýki, tegund 2 - lyf notuð við sykursýki - glyxambi, fastur skammt sambland af empagliflozin og linagliptin, er ætlað í fullorðnir 18 ára og eldri með tegund sykursýki 2:til að bæta blóðsykursstjórnun þegar sjúklingar og/eða sulphonylurea (su) og einn af monocomponents af glyxambi veita ekki fullnægjandi blóðsykursstjórnun;þegar þegar í meðferð með frjáls sambland af empagliflozin og linagliptin.

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - lungnasjúkdómur, langvarandi hindrandi - formóteróli og þannig brómíð - bevespi aerosphere er ætlað sem viðhald berkjuvíkkandi meðferð til að létta einkenni í fullorðinn sjúklinga með langvinn veikindi í lungum (llt).

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

bluefish pharmaceuticals ab - eplerenonum inn - filmuhúðuð tafla - 25 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - eplerenonum inn - filmuhúðuð tafla - 50 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - valsartanum inn - filmuhúðuð tafla - 160 mg